[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100365358":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":19,"centralContacts":24,"locations":29,"responsibleParty":46,"collaborators":18,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":52,"acronym":53,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":57,"enrollmentInfo":58,"targetDuration":18,"studyType":61,"phases":62,"briefSummary":64,"conditions":65,"keywords":67,"overallStatus":70,"whyStopped":18,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Assistance Publique - Hôpitaux de Paris","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"COGNITIVE TREATMENT OF DIETARY STIMULI AND BODY IMAGE","In order to explore the cognitive treatment of patients with early onset anorexia nervosa in front of images of silhouettes and food, it is currently used in the child psychiatry department of the Robert Debré Hospital, the eye-tracking method. Eye tracking is a non-invasive and painless method of recording the path of vision on images presented on a computer screen. In order to understand the specificities of the eye path in sick patients, we will compare the data with those of controls without eating disorders.",[12],"Other: STUDY OF THE COGNITIVE TREATMENT OF DIETARY STIMULI AND BODY IMAGE",[14],{"type":6,"name":15,"description":16,"armGroupLabels":17,"otherNames":18},"STUDY OF THE COGNITIVE TREATMENT OF DIETARY STIMULI AND BODY IMAGE","Describe the cognitive treatment of patients with early onset anorexia nervosa in response to specific stimuli of the disorder (eating and body images), compared to age- and sex-matched control subjects:\n\n* children controls not achieved with normal BMI;\n* children with unbalanced insulin-dependent type 1 diabetes, therefore subject to a strict diet that requires good nutritional knowledge and no weight judgment disorders.",[9],null,[20],{"name":21,"affiliation":22,"role":23},"Clarke Julia, PhD","APHP","PRINCIPAL_INVESTIGATOR",[25],{"name":21,"role":26,"phone":27,"phoneExt":18,"email":28},"CONTACT","01 40 03 22 96","julia.clarke@aphp.fr",[30],{"facility":31,"status":32,"city":33,"state":18,"zip":34,"country":35,"countryCode":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Hôpital Robert Debré","RECRUITING","Paris","75019","France","FR",{"type":38,"coordinates":39},"Point",[40,41],2.3488,48.85341,{"lat":41,"lon":40},[44],{"name":45,"role":26,"phone":18,"phoneExt":18,"email":28},"Clarke Julia, PHD",{"type":47,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100365358","exploration-of-the-mechanisms-of-vulnerability-of-anorexia-nervosa-at-an-early-age--study-of-the-cognitive-treatment-of-food-stimuli-and-body-image-100365358",false,"NCT04037215","Exploration of the Mechanisms of Vulnerability of Anorexia Nervosa at an Early Age : Study of the Cognitive Treatment of Food Stimuli and Body Image","AMDP","Inclusion Criteria:\n\nPatients with anorexia nervosa.\n\n* Age 8 to 14 years,\n* Early AM diagnosis (AM DSM-5 criteria, and presence of primary amenorrhea at diagnosis for girls),\n* Follow-up in the Child Psychiatry Department of the Robert Debré Hospital,\n* Affiliation to a social security system,\n* Authorization of the holder(s) of parental authority and acceptance of the child to participate in this research.\n\nWitnesses from the general population:\n\n* Age 8 to 14 years,\n* Normal Height-weight development defined by: Weight, Height, BMI between 10° and 90° percentile for age and sex, without changing the growth curve.\n* Authorization of the holder(s) of parental authority and acceptance of the child to participate in this research\n\nWitnesses with type 1 diabetes:\n\n* Age 8 to 14 years,\n* Type 1 diabetes for more than a year,\n* Follow-up in the endocrinology department of the Robert Debré Hospital,\n* Normal height-weight development defined by: Weight, Height, BMI between 10° and 90° percentile for age and sex, without changing the growth curve.\n* No clear imbalance with HbA1c \\\u003C8.5%.\n* Authorization of the holder(s) of parental authority and acceptance of the child to participate in this research\n\nExclusion Criteria:\n\n* Patients with AM.\n* Existence of an intellectual deficit (IQ \\\u003C70). The patient will not be able to have a new IQ test within one year of inclusion.\n* Other Axis I disorder (Kiddie SAS)\n* Existence of a severe neurosensory disorder\n* Existence of a neurological disorder\n* other eating disorders(DSM-5)\n* Diabetes type 1\n\nWitnesses :\n\n* Any Axis I psychiatric disorder\n* Existence of an intellectual deficit\n* Existence of a severe neurosensory disorder\n* Existence of a neurological disorder\n* Long-term drug treatment (other than insulin for controls with type 1 diabetes)\n* Type 1 diabetes (for controls in the general population)\n\nPsychometric test taken in the year before inclusion","ALL","8 Years","14 Years",{"count":59,"type":60},90,"ESTIMATED","INTERVENTIONAL",[63],"NA","In order to explore the cognitive treatment of patients with early onset anorexia nervosa (AM) in front of images of silhouettes and food, we will use the eye-tracking method. While we hypothesize a judgment disorder in these patients, the exploration of implicit cognitive treatment without desirability bias is essential. Eye-tracking is a method of recording the eye path that provides qualitative and quantitative information on the visual exploration of subjects. The visual pathway depends on how the subject's attention is directed to a given stimulus, but also on certain cognitive traits (e.g., excessive attention to details) or symptoms (e.g., avoidance of caloric food images or attraction to thin images). It is therefore a non-invasive exploration tool, which provides information on how patients look at food images and silhouettes. This project will describe the cognitive treatment of dietary stimuli and body image in young patients with early onset AM. It could identify a biomarker of AM in the pediatric population and improve the diagnosis of the disease. A better diagnosis of AM in patients under 15 years of age is essential and will improve medical care and develop personalized medicine.",[66],"Anorexia Nervosa",[68,69],"eye tracking","cognitive processing","UNKNOWN","2021-10-15",{"date":73,"type":74},"2021-10-18","ACTUAL",{"date":76,"type":74},"2019-11-19",{"date":78,"type":60},"2022-12-19",{"name":5,"class":6},1]